Hemant Surgical Industries
add_icon

Hemant Surgical Industries

302.00
+5.15
(1.73%)
Market Cap
393.71 Cr
PE Ratio
48.11
Volume
47,200.00
Day High - Low
302.00 - 284.00
52W High-Low
367.10 - 89.99
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
393.71 Cr
EPS
7.70
PE Ratio
48.11
PB Ratio
3.38
Book Value
87.71
EBITDA
14.10
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
12.73
Debt to Equity
0.49
Forecast For
Actual

Company News

View All News
Caret
neutral
Hemant Surgical Industries Limited confirms entire shareholding remains in demat form with no rematerialisation requests received during Q4 FY26, meeting SEBI regulatory compliance.
positive
Hemant Surgical Industries Limited has entered into a C-ARM Development and Supply Agreement with GBT Korea Co., Ltd. to develop and localize x-ray generators and imaging devices for surgical procedures.
positive
Hemant Surgical Industries Limited enters strategic Semi Knocked Down manufacturing agreement with Sonomed Escalon, USA for ophthalmic ultrasound diagnostic devices with plans for 100% local manufacturing in India.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,467.40
#1 14,873.49
43.66
#1 1,759.00
22.62
#1 339
-16.90
61.12
214.13
1,139.31
56.24
408.40
32.64
30
-5.66
66.27
621.40
1,099.54
55.75
186.60
40.62
20
-
66.01
195.04
1,071.98
47.27
242.40
24.12
25
-58.33
57.71
158.21
703.26
#1 22.25
335.90
45.66
47
-127.80
57.80
382.15
662.53
51.44
251.30
45.01
17
-67.50
44.80
450.00
540.18
27.10
67.10
13.15
18
4.44
65.01
234.00
445.54
27.19
136.30
#1 107.77
16
-
54.53
302.00
#9 393.71
#7 48.11
#9 111.80
-
#9 8
-
61.94
263.83
251.74
23.54
122.10
19.24
1
#1 232.14
56.18
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
-84.54 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Yearly Financial Results

Annual Financials
2025
TTM
Revenue
112
0
Expenses
98
0
EBITDA
14
0
Operating Profit %
8 %
0 %
Depreciation
1
0
Interest
2
0
Profit Before Tax
11
0
Tax
2
0
Net Profit
8
0
EPS in ₹
7.70
0.00

Balance Sheet

Balance Sheet
2025
Total Assets
148
Fixed Assets
40
Current Assets
89
Capital Work in Progress
12
Investments
0
Other Assets
97
Total Equity & Liabilities
148
Current Liabilities
61
Non Current Liabilities
24
Total Equity
63
Reserve & Surplus
53
Share Capital
10

Cash Flow

Cash Flow
2025
Net Cash Flow
-4
Investing Activities
-30
Operating Activities
9
Financing Activities
18

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
73.56 %
73.56 %
73.56 %
73.56 %
73.56 %
58.90 %
58.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.39 %
0.15 %
0.15 %
DIIs
0.49 %
0.00 %
1.97 %
1.13 %
1.11 %
10.81 %
10.81 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.00 %
17.47 %
20.64 %
20.24 %
20.87 %
23.17 %
23.22 %
Others
14.94 %
8.97 %
3.82 %
5.07 %
4.06 %
6.97 %
6.91 %
No of Share Holders
830
722
1,229
1,248
1,229
748
758

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 160.50 154.50
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 147.00 146.55
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 106.00 105.00
30 Aug 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Aug 2025 234.00 292.00
23 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2025 290.70 352.65
12 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2025 290.00 290.00

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 201810 days ago
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 02, 2026
Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon USAMar 31, 2026
Closure of Trading WindowMar 27, 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 19, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.Nov 12, 2025
Board Meeting Outcome for Held On Wednesday November 12 2025Nov 12, 2025
Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For Half Year Ended On September 30 2025Nov 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Closure of Trading WindowSep 27, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 23, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Announcement under Regulation 30 (LODR)-AllotmentSep 18, 2025
Announcement under Regulation 30 (LODR)-AllotmentSep 16, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderSep 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Dispatch Of Letter To ShareholdersAug 29, 2025
Reg. 34 (1) Annual Report.Aug 29, 2025
Notice Of The 36Th Annual General Meeting (AGM) Of The Company To Be Held On September 23 2025Aug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Intimation For 36Th Annual General Meeting Scheduled To Be Held On Tuesday September 23 2025.Aug 28, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 28, 2025
Intimation Of Appointment Of Secretarial Auditor Cost Auditor And Internal Auditor.Aug 28, 2025
Board Meeting Outcome for Held On Thursday August 28 2025Aug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsAug 08, 2025
Notice Of An Extra-Ordinary General Meeting Of The CompanyAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Board Meeting Outcome for Held On Wednesday August 06 2025Aug 06, 2025
Closure of Trading WindowAug 01, 2025
Board Meeting Intimation for To Consider Proposal For Fund RaisingAug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Statement Of Deviation & VariationMay 28, 2025
Audited Results For Half And Financial Year Ended March 31 2025May 28, 2025
Board Meeting Outcome for Held On Wednesday May 28 2025May 28, 2025
Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For Half And Financial Year Ended On March 31 2025.May 16, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 13, 2025
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 24, 2025
Compliances-Certificate Under Reg. 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended December 31 2024.Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 02, 2025

Technical Indicators

RSI(14)
Neutral
60.07
ATR(14)
Less Volatile
17.20
STOCH(9,6)
Overbought
85.80
STOCH RSI(14)
Overbought
97.25
MACD(12,26)
Bullish
4.90
ADX(14)
Weak Trend
14.03
UO(9)
Bearish
51.66
ROC(12)
Uptrend And Accelerating
14.90
WillR(14)
Overbought
-11.75